Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company's expectations including the risks detailed from time to time in the Company's public disclosure. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. This news release contains forward-looking statements. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. To learn more about Groups by Novamind, please visit this link. "It's an innovation that reduces barriers to mental healthcare for many patients with unmet needs." "Groups by Novamind leverages economies of scale responsibly, allowing us to offer our services to a larger patient population," said Yaron Conforti, CEO and Director. 1 Research suggests suitability for several mental health conditions including emotional trauma, anxiety, depression, post-traumatic stress disorder and attention deficit hyperactivity disorder. Group therapy may unlock certain healing properties that foster recovery and improve mental health through decreased isolation, improved problem-solving and accountability, and greater empathy. ![]() I've witnessed countless times, firsthand, how the power of group-based treatment leads to improved accessibility and outcomes, often with ripple effects of patients' healing work spreading to their families and communities." ![]() Reid Robison, Chief Medical Officer, commented, "Our goal is to develop a robust care model and group therapy further strengthens our range of treatment options. Many of the group offerings will be eligible for reimbursement by major insurance providers.ĭr. Groups are designed to be inclusive and welcome patients with diverse needs that may be suited to educational, therapeutic or medical intervention, and range in duration and fee structure. Clinicians will offer group therapy options including psychedelic integration and in-person group psychedelic-assisted psychotherapy for four to 10 individuals delivered as drop-in sessions or multi-week curricula. ![]() Under the model, Novamind is piloting alternatives to traditional one-on-one therapy. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that it is launching Groups by Novamind, an expansion of the Company's clinical care model focused on increasing patient access to Novamind's evidence-based mental health treatments. TORONTO, ON / ACCESSWIRE / Ma/ Novamind Inc. Innovative in-person and virtual group offerings increase access to care and social connection
0 Comments
Leave a Reply. |